Home›Compare›eMed vs Raeliva

eMed vs Raeliva: Which Is Better?

Head-to-head comparison of eMed and Raeliva based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

eMed scores higher overall in our independent evaluation (66.5/100 vs 61.2/100), leading on trust & safety, experience, reputation. Raeliva comes out ahead on value, product range. Raeliva has the lower entry price (from $117/mo vs $300/mo), so the better value depends on which treatment you need.

67
eMed
Good

Employer-focused GLP-1 weight management platform using branded FDA-approved medications with 24/7 clinician support and included lab work.

Visit eMed
61

Raeliva is a 2026-launched GLP-1 and longevity storefront built on the CareValidate platform, with flat dose-independent pricing and prepay discounts.

Visit Raeliva

Score Breakdown

DimensioneMedRaeliva
Overall Score66.5/100 ✓61.2/100
Trust & Safety30%72/100 ✓60/100
Value25%50/10072/100 ✓
Experience20%75/100 ✓62/100
Product Range15%45/10055/100 ✓
Reputation10%68/100 ✓45/100

At a Glance

Founded20202026
HeadquartersMiami, FLSan Diego, CA
Publicly tradedNoNo
Treatment categories12
Treatments listed17
Starting price$300/mo$117/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryeMedRaeliva
Weight Loss / GLP-1$300–$450
GLP-1 Weight Management Program
$150–$219
Compounded Semaglutide Injections

eMed

+Dispenses only branded FDA-approved GLP-1s as a Novo Nordisk NovoCare Recognized Care Provider, with no compounded product
+Branded FDA-approved GLP-1 medications only — no compounding risk
+24/7 clinician support without appointment scheduling
−Shipping is not included in the published price and is reported separately at about $10 a month
−Primarily an employer and labor-union benefits business; the direct-to-consumer programme is a secondary channel
−Medication cost is separate and expensive: $550–$1,300/mo on top of $99/mo program fee
Read the full eMed review →

Raeliva

+Clear operator disclosure: names the platform operator, the billing/intake vendor (CareValidate), the medical group (Lion MDs, with physician NPIs) and six dispensing pharmacies
+Flat pricing at every dose for semaglutide and tirzepatide, published on each product page
+Accepts transfers at the patient's current GLP-1 dose after provider review, with no charge if not eligible
−Launched in 2026 with ~1,500 claimed patients and only 12 Trustpilot reviews, all five-star and posted within two months
−Lowest advertised rates require 6- or 12-month prepayment ($900–1,450 upfront), and dispensed medication is non-refundable
−Runs on CareValidate's white-label telehealth stack, so the clinical and billing experience is shared with other storefronts
Read the full Raeliva review →

eMed vs Raeliva — FAQ

Is eMed better than Raeliva?

▾

eMed scores higher overall in our independent evaluation (66.5/100 vs 61.2/100), leading on trust & safety, experience, reputation. Raeliva comes out ahead on value, product range. Raeliva has the lower entry price (from $117/mo vs $300/mo), so the better value depends on which treatment you need.

Is eMed or Raeliva cheaper?

▾

Raeliva has the lower starting price (from $117/mo vs $300/mo for eMed). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do eMed and Raeliva both offer?

▾

Both platforms treat Weight Loss / GLP-1. eMed covers 1 treatment category total and Raeliva covers 2.

Still deciding?

eMed alternativesRaeliva alternativesTake the Match Quiz